Behind the Scenes of Eli Lilly's Latest Options Trends
Behind the Scenes of Eli Lilly's Latest Options Trends
Financial giants have made a conspicuous bearish move on Eli Lilly. Our analysis of options history for Eli Lilly (NYSE:LLY) revealed 8 unusual trades.
金融巨头对礼来采取了明显的看跌举动。我们对礼来(纽约证券交易所代码:LLY)期权历史的分析显示了8笔不寻常的交易。
Delving into the details, we found 12% of traders were bullish, while 75% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $179,046, and 5 were calls, valued at $247,750.
深入研究细节,我们发现12%的交易者看涨,而75%的交易者表现出看跌趋势。在我们发现的所有交易中,有3笔是看跌期权,价值为179,046美元,5笔是看涨期权,价值247,750美元。
Predicted Price Range
预测的价格区间
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $400.0 to $1000.0 for Eli Lilly during the past quarter.
分析这些合约的交易量和未平仓合约,大公司似乎一直在关注礼来公司在过去一个季度的价格范围从400.0美元到1000美元不等。
Volume & Open Interest Trends
交易量和未平仓合约趋势
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Eli Lilly's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale trades within a strike price range from $400.0 to $1000.0 in the last 30 days.
交易期权时,查看交易量和未平仓合约是一个强有力的举动。这些数据可以帮助您跟踪礼来公司期权在给定行使价下的流动性和利息。下面,我们可以观察到过去30天内所有礼来鲸鱼交易的看涨和看跌期权交易量和未平仓合约的变化,其行使价在400.0美元至1000美元之间。
Eli Lilly Option Activity Analysis: Last 30 Days
礼来期权活动分析:过去 30 天
Largest Options Trades Observed:
观察到的最大期权交易:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
LLY | CALL | TRADE | BEARISH | 01/15/27 | $101.8 | $98.0 | $98.0 | $1000.00 | $98.0K | 91 | 10 |
LLY | PUT | TRADE | BEARISH | 12/06/24 | $84.05 | $77.35 | $84.04 | $875.00 | $75.6K | 15 | 10 |
LLY | PUT | TRADE | BEARISH | 12/19/25 | $71.55 | $67.0 | $71.55 | $750.00 | $71.5K | 320 | 10 |
LLY | CALL | TRADE | NEUTRAL | 01/17/25 | $400.9 | $393.6 | $397.0 | $400.00 | $39.7K | 371 | 1 |
LLY | CALL | TRADE | BEARISH | 11/29/24 | $41.05 | $36.25 | $37.75 | $755.00 | $37.7K | 199 | 10 |
符号 | 看跌/看涨 | 交易类型 | 情绪 | Exp。日期 | 问 | 出价 | 价格 | 行使价 | 总交易价格 | 未平仓合约 | 音量 |
---|---|---|---|---|---|---|---|---|---|---|---|
LLY | 打电话 | 贸易 | 粗鲁的 | 01/15/27 | 101.8 美元 | 98.0 美元 | 98.0 美元 | 1000.00 美元 | 98.0 万美元 | 91 | 10 |
LLY | 放 | 贸易 | 粗鲁的 | 12/06/24 | 84.05 美元 | 77.35 美元 | 84.04 美元 | 875.00 美元 | 75.6 万美元 | 15 | 10 |
LLY | 放 | 贸易 | 粗鲁的 | 12/19/25 | 71.55 美元 | 67.0 美元 | 71.55 美元 | 750.00 美元 | 71.5 万美元 | 320 | 10 |
LLY | 打电话 | 贸易 | 中立 | 01/17/25 | 400.9 美元 | 393.6 美元 | 397.0 美元 | 400.00 美元 | 39.7 万美元 | 371 | 1 |
LLY | 打电话 | 贸易 | 粗鲁的 | 11/29/24 | 41.05 美元 | 36.25 美元 | 37.75 美元 | 755.00 美元 | 37.7 万美元 | 199 | 10 |
About Eli Lilly
关于 Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
礼来是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。礼来公司的关键产品包括用于癌症的Verzenio;用于心脏代谢的Mounjaro、Zepbound、Jardiance、Trulicity、Humalog和Humulin;以及用于免疫学的Taltz和Olumiant。
Current Position of Eli Lilly
礼来公司目前的职位
- With a volume of 8,286, the price of LLY is up 0.07% at $788.76.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 67 days.
- LLY的交易量为8,286美元,价格上涨0.07%,至788.76美元。
- RSI 指标暗示,标的股票目前在超买和超卖之间保持中立。
- 下一份财报预计将在67天后公布。
What The Experts Say On Eli Lilly
专家对礼来公司的看法
A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $1022.5.
在过去的30天中,共有4位专业分析师对该股发表了看法,将平均目标股价设定为1022.5美元。
Unusual Options Activity Detected: Smart Money on the Move
检测到不寻常的期权活动:智能货币在移动
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.* Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Eli Lilly, targeting a price of $975. * An analyst from B of A Securities persists with their Buy rating on Eli Lilly, maintaining a target price of $1100. * An analyst from Wolfe Research has revised its rating downward to Outperform, adjusting the price target to $1000. * An analyst from Deutsche Bank has decided to maintain their Buy rating on Eli Lilly, which currently sits at a price target of $1015.
Benzinga Edge的不寻常期权委员会在潜在的市场推动者发生之前就发现了它们。看看大笔资金对你最喜欢的股票持有哪些头寸。点击此处查看。* 巴克莱银行的一位分析师坚持其立场,继续维持礼来增持评级,目标价为975美元。* A证券b的一位分析师坚持对礼来公司的买入评级,维持1100美元的目标价格。* 沃尔夫研究的一位分析师已将其评级下调至跑赢大盘,将目标股价调整为1000美元。* 德意志银行的一位分析师已决定维持对礼来公司的买入评级,目前的目标股价为1015美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
与仅交易股票相比,期权是一种风险更高的资产,但它们具有更高的获利潜力。严肃的期权交易者通过每天自我教育、扩大交易规模、关注多个指标以及密切关注市场来管理这种风险。